{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:52:37Z","timestamp":1787003557103,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73759-0","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:04:44Z","timestamp":1730891084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Direct conversion of urine-derived cells into functional motor neuron-like cells by defined transcription factors"],"prefix":"10.1038","volume":"14","author":[{"given":"Hiroaki","family":"Nagai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehisa","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"key":"73759_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd.2016.245","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi, Y., Inoue, H., Wu, J. C. & Yamanaka, S. Induced pluripotent stem cell technology: a decade of progress. Nat. Rev. Drug Discov. 16, 115\u2013130. https:\/\/doi.org\/10.1038\/nrd.2016.245 (2017).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"73759_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.stemcr.2021.11.015","volume":"17","author":"AJ Hulme","year":"2022","unstructured":"Hulme, A. J., Maksour, S., St-Clair Glover, M., Miellet, S. & Dottori, M. Making neurons, made easy: the use of Neurogenin-2 in neuronal differentiation. Stem Cell. Rep. 17, 14\u201334. https:\/\/doi.org\/10.1016\/j.stemcr.2021.11.015 (2022).","journal-title":"Stem Cell. Rep."},{"key":"73759_CR3","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nn.3425","volume":"16","author":"J Sandoe","year":"2013","unstructured":"Sandoe, J. & Eggan, K. Opportunities and challenges of pluripotent stem cell neurodegenerative disease models. Nat. Neurosci. 16, 780\u2013789. https:\/\/doi.org\/10.1038\/nn.3425 (2013).","journal-title":"Nat. Neurosci."},{"key":"73759_CR4","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1093\/brain\/awaa268","volume":"143","author":"P Nikolakopoulou","year":"2020","unstructured":"Nikolakopoulou, P. et al. Recent progress in translational engineered in vitro models of the central nervous system. Brain 143, 3181\u20133213. https:\/\/doi.org\/10.1093\/brain\/awaa268 (2020).","journal-title":"Brain"},{"key":"73759_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","volume":"142","author":"M Ieda","year":"2010","unstructured":"Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 142, 375\u2013386. https:\/\/doi.org\/10.1016\/j.cell.2010.07.002 (2010).","journal-title":"Cell"},{"key":"73759_CR6","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.stem.2014.01.003","volume":"14","author":"P Huang","year":"2014","unstructured":"Huang, P. et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell. Stem Cell. 14, 370\u2013384. https:\/\/doi.org\/10.1016\/j.stem.2014.01.003 (2014).","journal-title":"Cell. Stem Cell."},{"key":"73759_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2021.04.004","author":"J Mertens","year":"2021","unstructured":"Mertens, J. et al. Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer\u2019s patients. Cell. Stem Cell.https:\/\/doi.org\/10.1016\/j.stem.2021.04.004 (2021).","journal-title":"Cell. Stem Cell."},{"key":"73759_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.stem.2015.09.001","volume":"17","author":"J Mertens","year":"2015","unstructured":"Mertens, J. et al. Directly reprogrammed human neurons retain aging-Associated Transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell 17, 705\u2013718. https:\/\/doi.org\/10.1016\/j.stem.2015.09.001 (2015).","journal-title":"Cell Stem Cell"},{"key":"73759_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev-genet-120417-031534","volume":"52","author":"J Mertens","year":"2018","unstructured":"Mertens, J., Reid, D., Lau, S., Kim, Y. & Gage, F. H. Aging in a dish: iPSC-Derived and directly Induced neurons for studying brain aging and age-related neurodegenerative diseases. Annu. Rev. Genet. 52, 271\u2013293. https:\/\/doi.org\/10.1146\/annurev-genet-120417-031534 (2018).","journal-title":"Annu. Rev. Genet."},{"key":"73759_CR10","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1093\/hmg\/dds319","volume":"21","author":"JE Young","year":"2012","unstructured":"Young, J. E. & Goldstein, L. S. B. Alzheimer\u2019s disease in a dish: promises and challenges of human stem cell models. Hum. Mol. Genet. 21, R82\u2013R89. https:\/\/doi.org\/10.1093\/hmg\/dds319 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"73759_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev-pharmtox-010715-103548","volume":"56","author":"KM Haston","year":"2016","unstructured":"Haston, K. M. & Finkbeiner, S. Clinical trials in a dish: the potential of pluripotent stem cells to develop therapies for neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 56, 489\u2013510. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010715-103548 (2016).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"73759_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.celrep.2015.12.018","volume":"14","author":"ML Liu","year":"2016","unstructured":"Liu, M. L., Zang, T. & Zhang, C. L. Direct lineage reprogramming reveals Disease-Specific phenotypes of motor neurons from human ALS patients. Cell. Rep. 14, 115\u2013128. https:\/\/doi.org\/10.1016\/j.celrep.2015.12.018 (2016).","journal-title":"Cell. Rep."},{"key":"73759_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00359","author":"Y Tang","year":"2017","unstructured":"Tang, Y., Liu, M. L., Zang, T. & Zhang, C. L. Direct reprogramming rather than iPSC-based reprogramming maintains aging hallmarks in human motor neurons. Front. Mol. Neurosci.https:\/\/doi.org\/10.3389\/fnmol.2017.00359 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"73759_CR14","unstructured":"Sato, M. et al. in Frontiers in Molecular Neuroscience (2019)."},{"key":"73759_CR15","doi-asserted-by":"publisher","first-page":"16707","DOI":"10.1038\/s41598-019-53007-6","volume":"9","author":"G Xu","year":"2019","unstructured":"Xu, G. et al. Direct Conversion of Human urine cells to neurons by small molecules. Sci. Rep. 9, 16707. https:\/\/doi.org\/10.1038\/s41598-019-53007-6 (2019).","journal-title":"Sci. Rep."},{"key":"73759_CR16","doi-asserted-by":"publisher","DOI":"10.1242\/dev.097410","author":"BN Davis-Dusenbery","year":"2014","unstructured":"Davis-Dusenbery, B. N., Williams, L. A., Klim, J. R. & Eggan, K. How to make spinal motor neurons. Dev. (Cambridge)https:\/\/doi.org\/10.1242\/dev.097410 (2014).","journal-title":"Dev. (Cambridge)"},{"key":"73759_CR17","doi-asserted-by":"publisher","first-page":"7848","DOI":"10.1523\/jneurosci.1972-04.2004","volume":"24","author":"GB Miles","year":"2004","unstructured":"Miles, G. B. et al. Functional properties of motoneurons derived from mouse embryonic stem cells. J. Neurosci. 24, 7848\u20137858. https:\/\/doi.org\/10.1523\/jneurosci.1972-04.2004 (2004).","journal-title":"J. Neurosci."},{"key":"73759_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.stem.2011.07.014","volume":"9","author":"EY Son","year":"2011","unstructured":"Son, E. Y. et al. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell 9, 205\u2013218. https:\/\/doi.org\/10.1016\/j.stem.2011.07.014 (2011).","journal-title":"Cell Stem Cell"},{"key":"73759_CR19","doi-asserted-by":"publisher","first-page":"C1278","DOI":"10.1152\/ajpcell.00168.2002","volume":"283","author":"Y Yoshiko","year":"2002","unstructured":"Yoshiko, Y., Hirao, K. & Maeda, N. Differentiation in C2C12 myoblasts depends on the expression of endogenous IGFs and not serum depletion. Am. J. Physiology-Cell Physiol. 283, C1278\u2013C1286. https:\/\/doi.org\/10.1152\/ajpcell.00168.2002 (2002).","journal-title":"Am. J. Physiology-Cell Physiol."},{"key":"73759_CR20","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1128\/mcb.4.8.1449-1453.1984","volume":"4","author":"W Bains","year":"1984","unstructured":"Bains, W., Ponte, P., Blau, H. & Kedes, L. Cardiac actin is the major actin gene product in skeletal muscle cell differentiation in Vitro. Mol. Cell. Biol. 4, 1449\u20131453. https:\/\/doi.org\/10.1128\/mcb.4.8.1449-1453.1984 (1984).","journal-title":"Mol. Cell. Biol."},{"key":"73759_CR21","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","volume":"94","author":"RP Tomko","year":"1997","unstructured":"Tomko, R. P., Xu, R. & Philipson, L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. 94, 3352\u20133356. https:\/\/doi.org\/10.1073\/pnas.94.7.3352 (1997).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"73759_CR22","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/ncomms3183","volume":"4","author":"ML Liu","year":"2013","unstructured":"Liu, M. L. et al. Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons. Nat. Commun. 4, 2183. https:\/\/doi.org\/10.1038\/ncomms3183 (2013).","journal-title":"Nat. Commun."},{"key":"73759_CR23","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1038\/s41598-019-40421-z","volume":"9","author":"H Takizawa","year":"2019","unstructured":"Takizawa, H. et al. Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride. Sci. Rep. 9, 3807. https:\/\/doi.org\/10.1038\/s41598-019-40421-z (2019).","journal-title":"Sci. Rep."},{"key":"73759_CR24","doi-asserted-by":"publisher","unstructured":"Castillo Bautista, C. M. & Sterneckert, J. Progress and challenges in directing the differentiation of human iPSCs into spinal motor neurons. Front. Cell. Dev. Biol. 10. https:\/\/doi.org\/10.3389\/fcell.2022.1089970 (2023).","DOI":"10.3389\/fcell.2022.1089970"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73759-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73759-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73759-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:09:09Z","timestamp":1730891349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73759-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73759"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73759-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H. N., M. S. and H. I. are employees of Takeda Pharmaceutical Company Limited and own stock.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27011"}}